Latest News
FDA Approves Rezdiffra, the First Drug for NASH, a Form of Fatty Liver Disease
https://www.yalemedicine.org/news/rezdiffra-for-nash-nonalcoholic-steatohepatitis
March 24, 2024
FDA Approves Rezdiffra, the First Drug for NASH, a Form of Fatty Liver Disease
https://www.yalemedicine.org/news/rezdiffra-for-nash-nonalcoholic-steatohepatitis
March 24, 2024